Kewaunee Scientific Corporation (KEQU) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Kewaunee Scientific Corporation stock (KEQU) is currently trading at $34.18. Kewaunee Scientific Corporation PE ratio is 9.70. Kewaunee Scientific Corporation PS ratio (Price-to-Sales) is 0.34. Analyst consensus price target for KEQU is $28.00. WallStSmart rates KEQU as Hold.
- KEQU PE ratio analysis and historical PE chart
- KEQU PS ratio (Price-to-Sales) history and trend
- KEQU intrinsic value — DCF, Graham Number, EPV models
- KEQU stock price prediction 2025 2026 2027 2028 2029 2030
- KEQU fair value vs current price
- KEQU insider transactions and insider buying
- Is KEQU undervalued or overvalued?
- Kewaunee Scientific Corporation financial analysis — revenue, earnings, cash flow
- KEQU Piotroski F-Score and Altman Z-Score
- KEQU analyst price target and Smart Rating
Kewaunee Scientific Corporation
📊 No data available
Try selecting a different time range
KEQU Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Kewaunee Scientific Corporation (KEQU)
KEQU trades at a significant discount to its Graham intrinsic value of $193.28, offering a 79% margin of safety — a level value investors typically seek before buying.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.

Smart Analysis
Kewaunee Scientific Corporation (KEQU) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, revenue growth. Concerns around market cap and operating margin. Fundamentals are solid but monitor weak areas for improvement.
Kewaunee Scientific Corporation (KEQU) Key Strengths (5)
Paying less than $1 for every $1 of annual revenue
Revenue surging 46.90% year-over-year
Earnings per share surging 40.50% year-over-year
Trading at 1.38x book value, attractively priced
Solid profitability: $20 profit per $100 equity
Supporting Valuation Data
Kewaunee Scientific Corporation (KEQU) Areas to Watch (4)
Very thin margins with limited operational efficiency
Very thin margins, barely profitable
Micro-cap company with very limited liquidity and high volatility
Moderate institutional interest at 41.32%
Supporting Valuation Data
Kewaunee Scientific Corporation (KEQU) Detailed Analysis Report
Overall Assessment
This company scores 60/100 in our Smart Analysis, earning a C+ grade. Out of 9 metrics analyzed, 5 register as strengths (avg 9.0/10) while 4 fall into concern territory (avg 3.3/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Revenue Growth, EPS Growth. Valuation metrics including Price/Sales (0.34), Price/Book (1.38) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 19.80%. Growth metrics are encouraging with Revenue Growth at 46.90%, EPS Growth at 40.50%.
The Bear Case
The primary concerns are Operating Margin, Profit Margin, Market Cap. Profitability pressure is visible in Operating Margin at 6.77%, Profit Margin at 4.68%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 19.80% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 46.90% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. The weight of evidence leans positive, with more strengths than concerns. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Price/Sales, Revenue Growth) and negatives (Operating Margin, Profit Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
KEQU Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
KEQU's Price-to-Sales ratio of 0.34x trades 17% below its historical average of 0.41x (29th percentile). The current valuation is 52% below its historical high of 0.71x set in Apr 2018, and 48% above its historical low of 0.23x in May 2012. Over the past 12 months, the PS ratio has compressed from ~0.4x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Kewaunee Scientific Corporation (KEQU) · CONSUMER CYCLICAL › FURNISHINGS, FIXTURES & APPLIANCES
The Big Picture
Kewaunee Scientific Corporation is a strong growth company balancing expansion with improving profitability. Revenue reached 263M with 47% growth year-over-year. Profit margins are strong at 468.0%, reflecting pricing power and operational efficiency.
Key Findings
Revenue growing at 47% YoY, reaching 263M. This pace significantly outperforms most FURNISHINGS, FIXTURES & APPLIANCES peers.
ROE of 1980.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
What to Watch Next
Growth sustainability: can Kewaunee Scientific Corporation maintain 47%+ revenue growth, or will competition slow it down?
Sector dynamics: monitor FURNISHINGS, FIXTURES & APPLIANCES industry trends, competitive moves, and regulatory changes that could impact Kewaunee Scientific Corporation.
Bottom Line
Kewaunee Scientific Corporation offers an attractive blend of growth (47% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(5 last 3 months)
| Insider | Type | Shares |
|---|---|---|
HULL, THOMAS DAVID III Director, President, CEO | Sell | -2,177 |
| Insider | Type | Shares |
|---|---|---|
GARDNER, DONALD T. III Chief Financial Officer | Sell | -2,000 |
| Insider | Type | Shares |
|---|---|---|
HULL, THOMAS DAVID III Director, President, CEO | Sell | -629 |
| Insider | Type | Shares |
|---|---|---|
HULL, THOMAS DAVID III Director, President, CEO | Sell | -29 |
| Insider | Type | Shares |
|---|---|---|
HULL, THOMAS DAVID III Director, President, CEO | Sell | -884 |
Data sourced from SEC Form 4 filings
Last updated: 8:27:52 AM
About Kewaunee Scientific Corporation(KEQU)
NASDAQ
CONSUMER CYCLICAL
FURNISHINGS, FIXTURES & APPLIA...
USA
Kewaunee Scientific Corporation designs, manufactures and installs laboratory, sanitary and technical furniture products. The company is headquartered in Statesville, North Carolina.